Heart failure treatment study
Treatments studied
Part of Heart & circulation clinical trials.
This study tests a new drug called finerenone to see if it can improve heart function in people with a type of heart failure where the heart pumps normally but is stiff. It may help reduce symptoms and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a diagnosis of heart failure with a preserved ejection fraction, meaning your heart pumps blood normally but doesn't fill properly.
- You must have a certain score on a heart function test, or have other tests confirming the diagnosis.
- Your heart rhythm is normal (sinus rhythm) on an ECG.
- You must not have a pacemaker or defibrillator that paces your heart.
- Your kidney function and potassium levels must be within safe limits, and you must not be allergic to finerenone.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the heart muscle works in people with a type of heart failure where the heart pumps normally but doesn't fill properly. It aims to understand the cause better, which could lead to new treatments.
This trial tests a program for people with a type of heart failure called HFpEF, where the heart pumps normally but is too stiff to fill properly. It aims to help high-risk patients after they leave the hospital, potentially improving their health and quality of life.
This trial tests a new medicine called finerenone to see if it can reduce heart scarring and improve heart function in people with a certain type of heart failure (preserved ejection fraction). If you qualify, you may help researchers learn if this treatment can help you feel better and stay out of the hospital.
This trial tests a medication called finerenone to see if it helps people hospitalized for heart failure live longer and have fewer heart-related problems. It may be an option for those with a certain type of heart failure where the heart's pumping strength is mildly reduced or normal.
This study tests whether finerenone, a medication that may help the heart work better, can improve electrical stability in people with a certain type of heart failure (HFpEF). It aims to reduce irregular heart rhythms and improve overall heart health.
This trial tests a medication called Finerenone to see if it can improve heart structure and function in people with both diabetic kidney disease and heart failure. If you have type 2 diabetes, kidney problems, and heart failure with preserved pumping function, this study may explore a new treatment option for you.
Hear when a new Heart Failure With Preserved Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.